Xintera

Foundation date

19/02/2018

Sector

#Professional Services and Consulting

Subsector

Xintera provides services in health outcome research and strategic development consulting. We work with our clients to optimise product development pathways, evaluate and mitigate clinical and regulatory development risk, and navigate the financial constraints of early development.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024